Benoit Visseaux
Overview
Explore the profile of Benoit Visseaux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
129
Citations
1876
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berkell M, Gorska A, Smet M, Bachelet D, Gentilotti E, Guedes M, et al.
Euro Surveill
. 2025 Mar;
30(10).
PMID: 40084424
BackgroundEvolution of SARS-CoV-2 is continuous.AimBetween 01/2020 and 02/2022, we studied SARS-CoV-2 variant epidemiology, evolution and association with COVID-19 severity.MethodsIn nasopharyngeal swabs of COVID-19 patients (n = 1,762) from France, Italy,...
2.
Abou Chakra C, Blanquart F, Vieillefond V, Enouf V, Visseaux B, Haim-Boukobza S, et al.
Emerg Microbes Infect
. 2025 Mar;
:2466699.
PMID: 40071892
Background: The epidemiology of respiratory viruses and vaccine effectiveness (VE) in the community is not well described. This study assessed VE against a positive test of influenza (VEf) and SARS-CoV-2...
3.
Blanquart F, Vieillefond V, Visseaux B, Abou Chakra C, Nunes M, Jacques A, et al.
Euro Surveill
. 2025 Feb;
30(7).
PMID: 39980426
Influenza circulates at high levels in Europe since November 2024. Using a test-negative study based on data from French community laboratories between October 2024 and February 2025, we estimated vaccine...
4.
Wirden M, Tombette F, Lambert-Niclot S, Chaix M, Marque-Juillet S, Bouvier-Alias M, et al.
J Int AIDS Soc
. 2025 Jan;
28(2):e26416.
PMID: 39875664
Introduction: Molecular surveillance is an important tool for detecting chains of transmission and controlling the HIV epidemic. This can also improve our knowledge of molecular and epidemiological factors for the...
5.
Traore A, Charniga K, Grellet S, Terpant G, Da Cruz H, Lamy A, et al.
Euro Surveill
. 2025 Jan;
30(1.
PMID: 39790077
BackgroundEarly detection and characterisation of SARS-CoV-2 variants have been and continue to be essential for assessing their public health impact. In August 2023, Santé publique France implemented enhanced surveillance for...
6.
Supplisson O, Visseaux B, Haim-Boukobza S, Boutolleau D, Alizon S, Burrel S, et al.
Infect Dis (Lond)
. 2024 Jul;
56(11):931-945.
PMID: 38946531
Background: Information related to herpes simplex virus 1 and 2 (HSV-1 and 2), varicella-zoster virus (VZV), Epstein-Barr virus (EBV), and cytomegalovirus (CMV) seroprevalence in France is either lacking, incomplete, or...
7.
dHumieres C, Fouillet A, Verdurme L, Lakoussan S, Gallien Y, Coignard C, et al.
Euro Surveill
. 2024 Jun;
29(25).
PMID: 38904112
From April 2023 to May 2024, an unusual epidemic of parvovirus B19 (B19V) infections occurred in France. The number of B19V IgM-positive serologies was four times higher than in the...
8.
Gracias S, El Yaalaoui I, Visseaux B, Charpentier C, Descamps D, Martin C, et al.
Microbiol Spectr
. 2024 May;
12(7):e0389523.
PMID: 38809042
Importance: Unlike HIV-1 group M, the scarcity of studies on HIV-1 non-M groups (O, N, and P) presents challenges in understanding their susceptibility to antiretroviral treatments, particularly due to their...
9.
Visseaux B, Gautier J, Boulaire F, Coignard C, Vincent C, Greaume S, et al.
Pract Lab Med
. 2024 May;
39:e00390.
PMID: 38715659
Introduction: This study evaluated the clinical and analytical performances of the Access HBsAg and the Access HBsAg Confirmatory assays on the DxI 9000 Access Immunoassay Analyzer (Beckman Coulter, Inc.). Materials...
10.
High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients
Chenane H, Lingas G, Menidjel R, Laouenan C, Tubiana S, Descamps D, et al.
J Med Virol
. 2023 Nov;
95(11):e29247.
PMID: 38009713
The presence of free severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid-antigen in sera (N-antigenemia) has been shown in COVID-19 patients. However, the link between the quantitative levels of N-antigenemia...